Alice Martin of the Chicago office contributed an article to the current edition of Biotech Buzz. Alice authored"U.S. Supreme Court Will Not Review Patent Subject-Matter Eligibility of Sequenom's Diagnostic Method Patent Claims."
Newsletters
American Intellectual Property Association (AIPLA) Biotechnology Committee's Biotech Buzz - "U.S. Supreme Court Will Not Review Patent Subject-Mater Eligibility of Sequenom's Diagnostic Method Patent Claims"
July 26, 2016
Chicago
Subscribe
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
View Subscription Center
